Ran Rostoker

571 total citations
15 papers, 481 citations indexed

About

Ran Rostoker is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ran Rostoker has authored 15 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Ran Rostoker's work include Metabolism, Diabetes, and Cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Ran Rostoker is often cited by papers focused on Metabolism, Diabetes, and Cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Ran Rostoker collaborates with scholars based in Israel, United States and Argentina. Ran Rostoker's co-authors include Sagie Schif‐Zuck, Amiram Ariel, Charles N. Serhan, Simaan Assi, Derek LeRoith, Keren Bitton-Worms, Derek LeRoith, Eyal J. Scheinman, Zila Shen‐Orr and Sagi Abelson and has published in prestigious journals such as Oncogene, Endocrinology and Frontiers in Immunology.

In The Last Decade

Ran Rostoker

15 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Rostoker Israel 12 205 194 88 87 61 15 481
Clarissa Corinaldesi Italy 13 253 1.2× 174 0.9× 61 0.7× 83 1.0× 23 0.4× 21 584
Xiao‐Feng Lei Japan 13 258 1.3× 159 0.8× 54 0.6× 59 0.7× 25 0.4× 26 572
Xiaojun Zheng China 10 231 1.1× 139 0.7× 141 1.6× 92 1.1× 18 0.3× 19 534
Janice M. Kraniak United States 11 222 1.1× 84 0.4× 58 0.7× 104 1.2× 24 0.4× 15 497
Alena Nareika United States 12 189 0.9× 184 0.9× 120 1.4× 52 0.6× 18 0.3× 12 541
Valerie Atizado Saudi Arabia 7 221 1.1× 106 0.5× 70 0.8× 126 1.4× 18 0.3× 8 489
Liqiong Xue China 12 147 0.7× 83 0.4× 51 0.6× 147 1.7× 24 0.4× 33 411
Naveen K Somanna United States 10 211 1.0× 69 0.4× 56 0.6× 63 0.7× 16 0.3× 14 454
Chantle Edillor United States 5 227 1.1× 174 0.9× 76 0.9× 40 0.5× 19 0.3× 5 439

Countries citing papers authored by Ran Rostoker

Since Specialization
Citations

This map shows the geographic impact of Ran Rostoker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Rostoker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Rostoker more than expected).

Fields of papers citing papers by Ran Rostoker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Rostoker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Rostoker. The network helps show where Ran Rostoker may publish in the future.

Co-authorship network of co-authors of Ran Rostoker

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Rostoker. A scholar is included among the top collaborators of Ran Rostoker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Rostoker. Ran Rostoker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kang, Chifei, Ran Rostoker, Deniz Demircioğlu, et al.. (2021). TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer. Cells. 10(12). 3430–3430. 11 indexed citations
2.
Schif‐Zuck, Sagie, Ran Rostoker, Malgorzata J. Podolska, et al.. (2018). A 17-kDa Fragment of Lactoferrin Associates With the Termination of Inflammation and Peptides Within Promote Resolution. Frontiers in Immunology. 9. 644–644. 16 indexed citations
3.
Rostoker, Ran, et al.. (2017). Activating Transcription Factor-5 Knockdown Reduces Aggressiveness of Mammary Tumor Cells and Attenuates Mammary Tumor Growth. Frontiers in Endocrinology. 8. 173–173. 13 indexed citations
4.
Zelenko, Zara, et al.. (2016). Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression. Oncogene. 36(10). 1394–1403. 33 indexed citations
5.
Rostoker, Ran, et al.. (2016). CD24 cell surface expression in Mvt1 mammary cancer cells serves as a biomarker for sensitivity to anti-IGF1R therapy. Breast Cancer Research. 18(1). 51–51. 5 indexed citations
6.
Scheinman, Eyal J., et al.. (2015). Ovariectomy is associated with metabolic impairments and enhanced mammary tumor growth in MKR mice. Journal of Endocrinology. 227(3). 143–151. 12 indexed citations
7.
Rostoker, Ran, Sagi Abelson, Ravi Sachidanandam, et al.. (2015). CD24+ cells fuel rapid tumor growth and display high metastatic capacity. Breast Cancer Research. 17(1). 78–78. 25 indexed citations
8.
Rostoker, Ran, et al.. (2015). Highly specific role of the insulin receptor in breast cancer progression. Endocrine Related Cancer. 22(2). 145–157. 61 indexed citations
9.
Rostoker, Ran, et al.. (2015). Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms. Handbook of experimental pharmacology. 233. 355–372. 21 indexed citations
10.
Rostoker, Ran, Anitha D. Jayaprakash, Ravi Sachidanandam, & Derek LeRoith. (2015). Deep sequencing of mRNA in CD24− and CD24+ mammary carcinoma Mvt1 cell line. Genomics Data. 5. 399–401. 2 indexed citations
11.
Rostoker, Ran, et al.. (2013). Galectin-1 induces 12/15-lipoxygenase expression in murine macrophages and favors their conversion toward a pro-resolving phenotype. Prostaglandins & Other Lipid Mediators. 107. 85–94. 38 indexed citations
12.
Scheinman, Eyal J., Ran Rostoker, & Derek LeRoith. (2013). Cholesterol affects gene expression of the Jun family in colon carcinoma cells using different signaling pathways. Molecular and Cellular Endocrinology. 374(1-2). 101–107. 12 indexed citations
13.
Bitton-Worms, Keren, et al.. (2013). The Effect of Leptin Administration on Mammary Tumor Growth in Diabetic Mice. Hormone and Metabolic Research. 45(9). 655–659. 3 indexed citations
14.
Rostoker, Ran, et al.. (2013). Investigating New Therapeutic Strategies Targeting Hyperinsulinemia's Mitogenic Effects in a Female Mouse Breast Cancer Model. Endocrinology. 154(5). 1701–1710. 25 indexed citations
15.
Schif‐Zuck, Sagie, et al.. (2010). Saturated‐efferocytosis generates pro‐resolving CD11b low macrophages: Modulation by resolvins and glucocorticoids. European Journal of Immunology. 41(2). 366–379. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clarissa Corinaldesi Breakdown of academic impact, for papers by Xiao‐Feng Lei Breakdown of academic impact, for papers by Xiaojun Zheng Breakdown of academic impact, for papers by Janice M. Kraniak Breakdown of academic impact, for papers by Alena Nareika Breakdown of academic impact, for papers by Valerie Atizado Breakdown of academic impact, for papers by Liqiong Xue Breakdown of academic impact, for papers by Naveen K Somanna Breakdown of academic impact, for papers by Chantle Edillor
Rankless by CCL
2026